Chlamydophila pneumoniae (Chlamydia pneumoniae) accelerates the formation of complex atherosclerotic lesions in Apo E3-Leiden mice

Cardiovascular Research

Volumn 56, Issue 2, 2002, Pages 269-276

  Ezzahiri, R ^a   Nelissen Vrancken, H J M G ^a   Kurvers, H A J M ^a   Stassen, F R M ^a   Vliegen, I ^a   Grauls, G E L M ^a   Van Pul, M M L ^a   Kitslaar, P J E H M ^a   Bruggeman, C A ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Atherosclerosis; Immunology; Infection inflammation; Leukocytes; Macrophages

Indexed keywords

APOLIPOPROTEIN E3; CD3 ANTIGEN; EOSIN; HEMATOXYLIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BACTERIAL INFECTION; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; DISEASE COURSE; LONGITUDINAL STUDY; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; STAINING; T LYMPHOCYTE;

ANIMALS; AORTITIS; ARTERIOSCLEROSIS; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CHOLESTEROL; DIET, ATHEROGENIC; DISEASE PROGRESSION; FEMALE; HYPERCHOLESTEROLEMIA; MALE; MICE; MICE, INBRED C57BL; RISK FACTORS; T-LYMPHOCYTES; TRIGLYCERIDES;

EID: 0036839433     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(02)00544-8     Document Type: Article

References (41)

1. Ross R. Atherosclerosis - an inflammatory disease. New Engl J Med. 340:1999;115-1126.
2. Gupta S. Chlamydia pneumoniae, monocyte activation, and azithromycin in coronary heart disease. Am Heart J. 138:1999;S539-S541.
3. Danesh J., Collins R., Peto R. Chronic infections and coronary heart disease: is there a link? Lancet. 350:1997;430-436.
4. Saikku P., Leinonen M., Mattila K., et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 2:1988;983-986.
5. Valtonen V.V. Role of infections in atherosclerosis. Am Heart J. 138:1999;S431-S433.
6. Mayr M., Kiechl S., Willeit J., Wick G., Xu Q. Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis. Circulation. 102:2000;833-839.
7. Radke P.W., Merkelbach-Bruse S., Messmer B.J., et al. Infectious agents in coronary lesions obtained by endatherectomy: pattern of distribution, coinfection, and clinical findings. Coron Artery Dis. 12:2001;1-6.
8. Gupta S., Leatham E.W., Carrington D., et al. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation. 96:1997;404-407.
9. Bachmaier K., Neu N., de la Maza L.M., et al. Chlamydia infections and heart disease linked through antigenic mimicry. Science. 283:1999;1335-1339.
10. Anderson J.L., Muhlestein J.B., Carlquist J., et al. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study. Circulation. 99:1999;1540-1547.
11. Hu H., Pierce G.N., Zhong G. The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae. J Clin Invest. 103:1999;747-753.
12. Fong I.W., Chiu B., Viira E., Jang D., Mahony J.B. De Novo induction of atherosclerosis by Chlamydia pneumoniae in a rabbit model. Infect Immun. 67:1999;6048-6055.
13. Moazed T.C., Kuo C., Patton D.L., Grayston J.T., Campbell L.A. Experimental rabbit models of Chlamydia pneumoniae infection. Am J Pathol. 148:1996;667-676.
14. Moazed T.C., Campbell L.A., Rosenfeld M.E., Grayston J.T., Kuo C.C. Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. J Infect Dis. 180:1999;238-241.
15. Muhlestein J.B., Anderson J.L., Hammond E.H., et al. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation. 97:1998;633-636.
16. Liu L., Hu H., Ji H., et al. Chlamydia pneumoniae infection significantly exacerbates aortic atherosclerosis in an LDLR-/- mouse model within six months. Mol Cell Biochem. 215:2000;123-128.
17. Stary H.C., Chandler A.B., Dinsmore R.E., et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol. 15:1995;1512-1531.
18. Lutgens E., Daemen M., Kockx M., et al. Atherosclerosis in APOE*3-Leiden transgenic mice: from proliferative to atheromatous stage. Circulation. 99:1999;276-283.
19. de Boer O.J., van der Wal A.C., Becker A.E. Atherosclerosis, inflammation, and infection. J Pathol. 190:2000;237-243.
20. Mosorin M., Surcel H.M., Laurila A., et al. Detection of Chlamydia pneumoniae-reactive T lymphocytes in human atherosclerotic plaques of carotid artery. Arterioscler Thromb Vasc Biol. 20:2000;1061-1067.
21. Nadareishvili Z.G., Koziol D.E., Szekely B., et al. Increased CD8(+) T cells associated with Chlamydia pneumoniae in symptomatic carotid plaque. Stroke. 32:2001;1966-1972.
22. Zhou X., Nicoletti A., Elhage R., Hansson G.K. Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation. 102:2000;2919-2922.
23. Varadhachary A.S., Monestier M., Salgame P. Reciprocal induction of IL-10 and IL-12 from macrophages by low-density lipoprotein and its oxidized forms. Cell Immunol. 213:2001;45-51.
24. Nicoletti A., Paulsson G., Caligiuri G., Zhou X., Hansson G.K. Induction of neonatal tolerance to oxidized lipoprotein reduces atherosclerosis in ApoE knockout mice. Mol Med. 6:2000;283-290.
25. Hakkinen T., Karkola K., Yla-Herttuala S. Macrophages, smooth muscle cells, endothelial cells, and T-cells express CD40 and CD40L in fatty streaks and more advanced human atherosclerotic lesions. Colocalization with epitopes of oxidized low-density lipoprotein, scavenger receptor, and CD16 (Fc gammaRIII). Virchows Arch. 437:2000;396-405.
26. Haranaga S., Yamaguchi H., Friedman H., Izumi S.-I., Yamamoto Y. Chlamydia pneumoniae infects and multiplies in lymphocytes in vitro. Infect Immun. 69:2001;7753-7759.
27. van Vlijmen B.J., van den Maagdenberg A.M., Gijbels M.J., et al. Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice. J Clin Invest. 93:1994;1403-1410.
28. Roblin P.M., Dumornay W., Hammerschlag M.R. Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae. J Clin Microbiol. 30:1992;1968-1971.
29. Rothstein N.M., Quinn T.C., Madico G., Gaydos C.A., Lowenstein C.J. Effect of azithromycin on murine arteriosclerosis exacerbated by Chlamydia pneumoniae. J Infect Dis. 183:2001;232-238.
30. Moazed T.C., Kuo C., Grayston J.T., Campbell L.A. Murine models of Chlamydia pneumoniae infection and atherosclerosis. J Infect Dis. 175:1997;883-890.
31. Moazed T.C., Kuo C.C., Grayston J.T., Campbell L.A. Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse. J Infect Dis. 177:1998;1322-1325.
32. Nakashima Y., Plump A.S., Raines E.W., Breslow J.L., Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb. 14:1994;133-140.
33. Blessing E., Lin T.M., Campbell L.A., et al. Chlamydia pneumoniae induces inflammatory changes in the heart and aorta of normocholesterolemic C57BL/6J mice. Infect Immun. 68:2000;4765-4768.
34. Hansson G. Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol. 21:2001;1897-1899.
35. Kaul R., Uphoff J., Wiedeman J., Yadlapalli S., Wenman W.M. Detection of Chlamydia pneumoniae DNA in CD3+ lymphocytes from healthy blood donors and patients with coronary artery disease. Circulation. 102:2000;2341-2346.
36. Aalto-Setala K., Laitinen K., Erkkila L., et al. Chlamydia pneumoniae does not increase atherosclerosis in the aortic root of apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 21:2001;578-584.
37. Caligiuri G., Rottenberg M., Nicoletti A., Wigzell H., Hansson G.K. Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice. Circulation. 103:2001;2834-2838.
38. Paigen B., Ishida B.Y., Verstuyft J., Winters R.B., Albee D. Atherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice. Arteriosclerosis. 10:1990;316-323.
39. Campbell L.A., O'Brien E.R., Cappuccio A.L., et al. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis. 172:1995;585-588.
40. Danesh J., Whincup P., Walker M., et al. Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis. Br Med J. 321:2000;208-213.
41. Ramirez J.A. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group. Ann Intern Med. 125:1996;979-982.